SAVA Competitors & Alternatives
Compare Cassava Sciences Inc with similar stocks in the same industry
Biotechnology
SAVA
Main Stock$2.38
Tradestie Score
48
Market Cap
$154.59M
Analyst Upside
+236.1%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.54
|
$211.22M | - | 46 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.75
|
$202.58M | - | 64 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$6.93
|
$170.45M | - | 42 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.49
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.05
|
$154.27M | - | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.19
|
$133.50M | - | 63 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.49
|
$114.01M | - | 63 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.97
|
$110.20M | - | 57 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.92
|
$84.52M | - | 42 | Compare |
More SAVA Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry